GlassScriptPhysician profile
Keith Peter Ameyaw
NPI 1427611748
$7,279.79
in general payments reported to CMS, 2019-2025
9 companies · $6,909 in 2025
The $6,909 reported for 2025 was more than what 87% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.28 · 2024: $307 · 2025: $6,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,648 · Food and Beverage: $1,519 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,647.74 |
| Food and Beverage | $1,518.77 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,647.74 | 2025 | |
| Argon Medical Devices, INC. | $390.59 | 2024-2025 | Clot Management, Clot Management |
| Angiodynamics, INC. | $336.43 | 2025 | Alphavac, Angiovac |
| Penumbra, INC. | $209.78 | 2022-2025 | Indigo System |
| Terumo Medical Corporation | $180.19 | 2024-2025 | Angio-Seal, Azur Cx Detachable, Glidewire |
| Boston Scientific Corporation | $178.25 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Administration Set |
| Stryker Corporation | $169.93 | 2025 | Flowtriever |
| Cardiva Medical, INC. | $116.88 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Ameyaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.